Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21

Yoichi Nakanishi, Xin Hai Pei, Koichi Takayama, Feng Bai, Miiru Izumi, Kanehito Kimotsuki, Koji Inoue, Takahiro Minami, Hiroshi Wataya, Nobuyuki Hara

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Polycyclic aromatic hydrocarbon carcinogens (PAHs) and their metabolites have been found to result in a rapid accumulation of p53 gene product in human and mouse cells. However, the induced p53 protein was reported to be transcriptionally inactive. In the present study, the induction of p53 target gene expression after the treatment with either benzo(a)pyrene (B[a]P) or 1-nitropyrene (1-NP) was investigated. A marked induction of messenger RNA (mRNA) expressions of Mdm2, Bax, and p21 was detected in wild-type p53-expressing cells after the treatment with either B[a]P or 1-NP, whereas no significant change in mRNA expression of these genes was observed in p53-negative and mutant cells. 1-NP activated the p21 promoter in a p53-dependent manner. Binding activity of p53 to a p53 consensus sequence increased after the treatment in wild-type p53-expressing cells. Nevertheless, the induced mRNA levels of the p21 did not result in a proportional p21 protein increase, indicating the possibility of post-transcriptional regulation of the protein. With the addition of MG-132, a proteasome inhibitor, to B[a]P or 1-NP treatments, both p21 and p53 protein levels were increased; however, the increase in p21 protein levels was significantly larger than the increase in p53 protein levels. PAHs treatment increased the level of ubiquitinated p21. These results suggest that the p21 product is degraded by the ubiquitin-proteasome system. We conclude that PAHs-induced p53 protein is transcriptionally active.

Original languageEnglish
Pages (from-to)747-754
Number of pages8
JournalAmerican journal of respiratory cell and molecular biology
Volume22
Issue number6
DOIs
Publication statusPublished - Jan 1 2000

Fingerprint

1-nitropyrene
Ubiquitination
Polycyclic Aromatic Hydrocarbons
Carcinogens
Stabilization
Polycyclic aromatic hydrocarbons
Proteins
p53 Genes
Messenger RNA
Genes
Gene Expression
Proteasome Inhibitors
Benzo(a)pyrene
Consensus Sequence
Proteasome Endopeptidase Complex
Metabolites
Ubiquitin
Gene expression

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. / Nakanishi, Yoichi; Pei, Xin Hai; Takayama, Koichi; Bai, Feng; Izumi, Miiru; Kimotsuki, Kanehito; Inoue, Koji; Minami, Takahiro; Wataya, Hiroshi; Hara, Nobuyuki.

In: American journal of respiratory cell and molecular biology, Vol. 22, No. 6, 01.01.2000, p. 747-754.

Research output: Contribution to journalArticle

Nakanishi, Yoichi ; Pei, Xin Hai ; Takayama, Koichi ; Bai, Feng ; Izumi, Miiru ; Kimotsuki, Kanehito ; Inoue, Koji ; Minami, Takahiro ; Wataya, Hiroshi ; Hara, Nobuyuki. / Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. In: American journal of respiratory cell and molecular biology. 2000 ; Vol. 22, No. 6. pp. 747-754.
@article{a7de06e963f544d2ac931f90c3feab91,
title = "Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21",
abstract = "Polycyclic aromatic hydrocarbon carcinogens (PAHs) and their metabolites have been found to result in a rapid accumulation of p53 gene product in human and mouse cells. However, the induced p53 protein was reported to be transcriptionally inactive. In the present study, the induction of p53 target gene expression after the treatment with either benzo(a)pyrene (B[a]P) or 1-nitropyrene (1-NP) was investigated. A marked induction of messenger RNA (mRNA) expressions of Mdm2, Bax, and p21 was detected in wild-type p53-expressing cells after the treatment with either B[a]P or 1-NP, whereas no significant change in mRNA expression of these genes was observed in p53-negative and mutant cells. 1-NP activated the p21 promoter in a p53-dependent manner. Binding activity of p53 to a p53 consensus sequence increased after the treatment in wild-type p53-expressing cells. Nevertheless, the induced mRNA levels of the p21 did not result in a proportional p21 protein increase, indicating the possibility of post-transcriptional regulation of the protein. With the addition of MG-132, a proteasome inhibitor, to B[a]P or 1-NP treatments, both p21 and p53 protein levels were increased; however, the increase in p21 protein levels was significantly larger than the increase in p53 protein levels. PAHs treatment increased the level of ubiquitinated p21. These results suggest that the p21 product is degraded by the ubiquitin-proteasome system. We conclude that PAHs-induced p53 protein is transcriptionally active.",
author = "Yoichi Nakanishi and Pei, {Xin Hai} and Koichi Takayama and Feng Bai and Miiru Izumi and Kanehito Kimotsuki and Koji Inoue and Takahiro Minami and Hiroshi Wataya and Nobuyuki Hara",
year = "2000",
month = "1",
day = "1",
doi = "10.1165/ajrcmb.22.6.3877",
language = "English",
volume = "22",
pages = "747--754",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21

AU - Nakanishi, Yoichi

AU - Pei, Xin Hai

AU - Takayama, Koichi

AU - Bai, Feng

AU - Izumi, Miiru

AU - Kimotsuki, Kanehito

AU - Inoue, Koji

AU - Minami, Takahiro

AU - Wataya, Hiroshi

AU - Hara, Nobuyuki

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Polycyclic aromatic hydrocarbon carcinogens (PAHs) and their metabolites have been found to result in a rapid accumulation of p53 gene product in human and mouse cells. However, the induced p53 protein was reported to be transcriptionally inactive. In the present study, the induction of p53 target gene expression after the treatment with either benzo(a)pyrene (B[a]P) or 1-nitropyrene (1-NP) was investigated. A marked induction of messenger RNA (mRNA) expressions of Mdm2, Bax, and p21 was detected in wild-type p53-expressing cells after the treatment with either B[a]P or 1-NP, whereas no significant change in mRNA expression of these genes was observed in p53-negative and mutant cells. 1-NP activated the p21 promoter in a p53-dependent manner. Binding activity of p53 to a p53 consensus sequence increased after the treatment in wild-type p53-expressing cells. Nevertheless, the induced mRNA levels of the p21 did not result in a proportional p21 protein increase, indicating the possibility of post-transcriptional regulation of the protein. With the addition of MG-132, a proteasome inhibitor, to B[a]P or 1-NP treatments, both p21 and p53 protein levels were increased; however, the increase in p21 protein levels was significantly larger than the increase in p53 protein levels. PAHs treatment increased the level of ubiquitinated p21. These results suggest that the p21 product is degraded by the ubiquitin-proteasome system. We conclude that PAHs-induced p53 protein is transcriptionally active.

AB - Polycyclic aromatic hydrocarbon carcinogens (PAHs) and their metabolites have been found to result in a rapid accumulation of p53 gene product in human and mouse cells. However, the induced p53 protein was reported to be transcriptionally inactive. In the present study, the induction of p53 target gene expression after the treatment with either benzo(a)pyrene (B[a]P) or 1-nitropyrene (1-NP) was investigated. A marked induction of messenger RNA (mRNA) expressions of Mdm2, Bax, and p21 was detected in wild-type p53-expressing cells after the treatment with either B[a]P or 1-NP, whereas no significant change in mRNA expression of these genes was observed in p53-negative and mutant cells. 1-NP activated the p21 promoter in a p53-dependent manner. Binding activity of p53 to a p53 consensus sequence increased after the treatment in wild-type p53-expressing cells. Nevertheless, the induced mRNA levels of the p21 did not result in a proportional p21 protein increase, indicating the possibility of post-transcriptional regulation of the protein. With the addition of MG-132, a proteasome inhibitor, to B[a]P or 1-NP treatments, both p21 and p53 protein levels were increased; however, the increase in p21 protein levels was significantly larger than the increase in p53 protein levels. PAHs treatment increased the level of ubiquitinated p21. These results suggest that the p21 product is degraded by the ubiquitin-proteasome system. We conclude that PAHs-induced p53 protein is transcriptionally active.

UR - http://www.scopus.com/inward/record.url?scp=0034089593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034089593&partnerID=8YFLogxK

U2 - 10.1165/ajrcmb.22.6.3877

DO - 10.1165/ajrcmb.22.6.3877

M3 - Article

C2 - 10837373

AN - SCOPUS:0034089593

VL - 22

SP - 747

EP - 754

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 6

ER -